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Abstract
Introduction: Iron deficiency anemia is one of the leading causes of morbidity and
mortality among pregnant women in developing country. Eventhogh prenatal iron folic
acid supplement has paramount contribution for reducing anemia; in Ethiopia its
coverage is very low.
Objective: The objective of this study was to Assess Adherence of prenatal iron/folic
acid supplement and its associated factors among Antenatal Care attendant mothers of
Goba woreda, South East Ethiopia.
Methods: A community based cross-sectional study was conducted at Goba woreda,
from March10 to May 10 2014. Data were collected by using pretested questionnaires.
A total of 405 mothers were included in the study. The response rates of the study were
96.4%. Data were entered and analysis using SPSS version 20. Both bivarate and
multivariate logistic regression analysed was carried out to see significant association, a
P-value less than 0.05 was considered as significant association.
Result: This study revealed that 18% of the studied subjects had adhered to IFA
supplement. Educational status of mother, knowledge on anemia (AOR =0.41 (95% CI
0.20, 0.84)), knowledge on benefit of iron folic acid (AOR =.38 (95% CI .20-0.77), health
Education during prenatal visit (AOR =4.03 (95% CI 1.4- 11.5) and history of abortion
(AOR=3.79(1.68-8.55) were found to be factors associated with adherence to iron folic
acid supplement.
Conclusion: The adherence rate to IFA supplements is low among pregnant women
attending ANC. Educational status of mother, Knowledge on anemia, Knowledge on benefits
of iron folic acid, and Health education at the time of supplement collection are Factors with
significantly associated to adherence of IFA.
Sensitization of the community about anemia and IFA supplement and continuous and
timely supply of IFA to all health facilities would be very important
Key words: Anemia, Adherence to iron/folic acid Supplement, pregnant women
11 Introduction
1.1 Statement of the problem
Anemia is a global public health problem affecting two billion people worldwide.
Globally, 41.8% of pregnant women and 30.2% of non-pregnant women are anemic(1).
At least half of this anemia burden is assumed to be due to iron deficiency(2). Many
studies documented the adverse effects of maternal anemia, 12.8% and 3.7% of
maternal mortality in Asia and Africa respectively is directly attribute-able to anemia(3).
In Ethiopia; anemia is the severe problem affecting 62.7% of pregnant mothers and
52.3% non-pregnant women(4, 5). For women, the consequences of anemia include
reduced energy and capacity for work poor pregnancy and birth outcomes including
premature delivery, low birth weight, and increased prenatal mortality, and increased
risk of death during delivery and postpartum. It is estimated that as many as 20% of
maternal deaths are caused by anemia and that anemia may be an associated cause in
as many as 50% of maternal deaths worldwide(6).
As a public health measure, iron supplementation has been the recommended strategy
for alleviating anemia in pregnant women. WHO recommended daily dose of Iron: 30–
60 mg of elemental iron and Folic acid: 400 μg (0.4 mg) On daily bases throughout
pregnancy(7).
To combat Iron deficiency anemia, many developing countries including Ethiopia have
systems for delivery of iron and folic acid and have a national policy to prevent and treat
anemia in pregnancy. This includes the provision IFA supplement to all pregnant
women. The recommended dose by the Ministry of Health in Ethiopia is 60mg/day for
90 days for iron and 400μg of folic acid daily(8, 9). And, Although National Nutrition
Strategy adopted key target of increasing the proportion of mothers who get IFS for
more than 90 days during pregnancy and the post-partum period to 50% by 2015 there
discrepancy in the ANC coverage and the IFA intake level. The 2011 DHS documented
IFA supplement of 17%. More importantly the IFA intake 90 or more tablets found to be
0.4%(10).
Studies conducted in South-East Asia, Latin America and in only a few African
Countries have shown that one of the main reasons why these programs have been
less effective than anticipated is associated with a number of factors, including: 1.
2gastrointestinal side effects that can occur with taking iron; (2) inadequate Supply of
tablets (including limited resources to purchase tablets); (3) inadequate counseling of
patients by healthcare providers concerning the utility of tablets and possible transient
side-effects; (4) poor utilization of prenatal health-care services; (5) lack of knowledge
and/or patient fears about the tablets; and (6) community beliefs, attitudes and practices
that affect women’s perception regarding tablet use(11-13).
31.2. Literature review
1.2.1. Magnitude of Anemia among pregnant women
World Health Organization (WHO) estimates that anemia affects about 2 billion people
in the world, or about one-third of the population, women suffering the most. World
Health Organization (WHO) estimate, the prevalence of anemia in pregnant women is
68%. in Africa its prevalence is estimated to be 66.8%(14).
In Ethiopia, anemia is the severe problem affecting pregnant mothers largely(15). A
ccording to EDHS report of 2011, 17% of Ethiopian women age 15-49 are anemic, with
13% mild anemia, 3% having moderate anemia, and 1 % having severe anemia. A
higher proportion of pregnant women are anemic 22% than women who are
breastfeeding (19 %) and women who are neither pregnant nor breastfeeding 15%.
Anemia can result from non-nutritional factors, such as hemorrhage, infection, chronic
disease states and from nutritional ones, including deficiencies of iron, certain vitamins,
copper, and protein. Iron deficiency remains the major cause of anemia and is the most
widespread single nutrient deficiency in the world. It is estimated that 75% of anemia is
related to iron and folic acid deficiency(16).
Anemia is the most common health condition affecting women during pregnancy and
leads to adverse health outcomes of both the mother and infant, there is an increased
iron folic acid requirement during pregnancy due to greater expansion in plasma volume
that results in hemoglobin level(17).
The consequences of anemia in pregnancy include: still-birth, low birth weight and pre-
term births, reduced work capacity, decreased mental performance, low tolerance to
infections, death from anemic heart failure and maternal deaths due to uncontrolled
bleeding(18)
1.2.2. Iron folic acid supplement and associated factors
As a public health measure, iron supplementation has been the recommended strategy
for alleviating anemia in pregnant women, WHO Recommended daily dose of 60mg/day
of iron and 400μg of folic acid daily for six months during Pregnancy in developing
countries (9). Several randomized controlled studies compared hematological changes
in pregnant women who received iron supplementation, ranging between 15 and 240
mg/ day(19-22) Studies conducted on iron supplementations among pregnant women
4indicate that, 120 mg elemental iron given daily from mid pregnancy until delivery
significantly reduced the prevalence of anemia(23).
Unfortunately most of iron supplementation program has been less effective than
expected. According to EDHS 2011 In Ethiopia Eighty-three percent of women did not
take iron tablets during their last pregnancy. Fifteen percent took them for less than 60
days, and less than 1 percent took them for 90 days or more during their last
pregnancy. There are very small differences in daily iron supplements between urban
and rural women and among regions. In general, The proportion of women who took
iron during each length of time increases with educational level(9, 24).
An institutional based study conducted among pregnant women attending antenatal
clinic at Thika district hospital of Kenya show 24.5% adherence rate to iron/folic acid
supplements another quantitative and qualitative study conducted in Cambodia show
adherence rate of 47%. Another study conducted in vientiane municipality India on 340
pregnant women show 34.4% adherence rate(25, 26).
There are different reasons by pregnant mother for not taking their supplement, a study
conducted In Senegal on Two hundred and twenty-one pregnant women reveals that
(58%) were motivated by: (1) the perception of improved health upon taking the tablets
(2) the insistence by midwives that they take the tablets; and (3) the mention that the
tablets would improve health, Women with low compliance (42%) reported: (1) the
experience of side-effects that they associated with the tablets (2) misunderstanding
that they needed to continue taking the tablets throughout pregnancy (and (3)
forgetfulness(27).
Studies have shown that women’s level of adherence influenced by heir economical and
social status in addition to obstetric factors like parity and history of past obstetric
problem. As a woman’s social status and her health are intrinsically related, her low
status is often the cause of poor access to health care. And a study in India Shows that
women with higher education and better income are more likely to adhere for IFA
supplement. Distance was also identified as an important environmental factor of taking
iron/folic acid supplement (28, 29).
Availability of services and their accessibility (both geographic and economic) are
important factors which determine maternal IFA intake and they are usually determined
5by women’s household income, place of residence and its distance from health
services(30)
Regarding the association between numbers of pregnancy, number of delivery and ANC
with adherence IFA shows contradictory findings. According to a study conducted in
Egypt the number of  ANC visit is significantly associated with adherence, in contrast
availability of ANC number of pregnancy and number of delivery did not show effect on
adherence(31). Another study conducted in Senegal show 23% adherence rate.
Positive association factors found between visits. No associations were found between
adherence and age, education level, marital status, and number of previous
pregnancies(32)
Other study show on knowledge of mothers about maternal anemia and IFA supplement
was significantly lower for women with poor adherence and than those with good
adherence(33)
A study done in rural Bangladesh showd that knowledge of mothers about anemia and
IFA was very low and the level of women’s knowledge has increased after awareness-
raising activities are done. Women who have provided the awareness creation were
more likely to adhered IFA compared to those who did not receive. This finding is in
favor of the assumptions that women’s knowledge on anemia and IFA is important in
influencing AFI supplement (34)
6Figure 1: conceptual fram work of factors affecting adherence to Iron Folic acid
supplement. (Source; Adopted from WHO 2003 chronic disease treatement Adherence)
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71.3. Justification
Anemia during pregnancy is a major public health problem and remains one of the top
causes of maternal mortality with 110,000 million maternal deaths (35). Ethiopia is one
of the highest rates of maternal mortality (MMR) in the world. Failure to reduce MMR
prevent from achieving Millennium Development Goal that is to reduce maternal
mortality to 267 per 100,000 live birth by year 2015(36) .
Eventhogh iron folic acid (IFA) Supplementation during pregnancy is among the
methods to reduce mortality, in Ethiopia the coverage is very low, In addition there are
limited studies conducted on this topic.
There for findings from this study will give valuable information on adherence rate of IFA
and determinate factors for concerned bodies
82. Objectives
2.1 General objective
 To assess adherence to prenatal iron/folic acid supplement and its associated
factors among ANC attendant mothers of Goba woreda, South East Ethiopia.
2.2 Specific objectives
 To determine adherence to prenatal iron/folic acid supplement among ANC
attendant mothers.
 To identify factors affecting adherence to prenatal iron/folate supplement among
ANC attendant mothers.
93. Methodology
3.1. Study design
A cross-sectional community based study was employed.
3.2. Study area and period
The study was conducted in Bale zone Goba Woreda oromia regional state, south east
Ethiopia, Which is located 430 km from Addis Ababa. The altitude of the town is 2510 to
2800 meters above sea level. The woreda has two urban and twelve rural Kebles.
The total population of the woreda is estimated to be 89, 858 with 3, 200 pregnat women
There are one referral hospital four health center and more than 12 health posts in the
woreda.
The study was conducted from March 10 2014 to May 10 2014.
3.3. Source population
The source population was all third trimester pregnant and PNC mothers who was
attendants of ANC and residing in the town during the study period.
3.4. Study population
All third trimester pregnant and post natal mother who were attendants of ANC and
included in the sample.
3.5 Inclusion and exclusion criteria
3.5.1. Inclusion criteria
All pregnet women who took iron folic acid supplementation during their ANC follow up
were included in the study
3.5.1. Exclusion criteria
Mothers who were seriously ill at time of data collection were excluded from the study
3.6. Sample size determination
Sample size was computed based on the formula used to estimate a single population
proportion formula with a 95 % confidence interval and 5 % marginal of error.
Since current actual adherence rate is not known, a rate of 50% was preferred to obtain
the large possible sample size.
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A z-value of 1.96 was used as at reliability coefficient corresponding to 95% Confidence
level and d of 5 %.
Where
n =is the minimum sample required
p=the prevalence rate to adherence to prenatal folic acid supplement (50%)
d=the margin of error
z= the upper percentileh of the standered normal distribution
The sample size was 384 and with adjustment for non-response (10%) n=
(384+38), the final sample size was 422.
3.7. Sampling and Data collection procedure
3.7.1. Sampling technique
After secondary data were obtained from health extension workers survey was
performed to identify the study subjects. A total of 478 third trimester pregnant and PNC
mothers were identified. Since the study subjects are few census were performed in all
study subjects. 40 of them claimed as not taking the supplement, 5 of them were
seriously ill, 3 of them were left their house for different reasons and 15 of them were
none respondent.
Out of the total subjects 405 of them were involved in the study.
3.7.2. Data collection tools and procedures
Data were collected using pretested questioner by interview. The questioners were
prepared in English and then translated in to afan Oromo and Amharic. A total of six
diploma nurse data collectors and two BSC nurse supervisors were involved in the
study.
3.8. Data quality management
To ensure quality of data a three days training was provided to data collectors and
supervisors. Data collection questioner was pretested using 5% of similar population of
2
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Kebles of other woreda. Regular supervision was made during data collection. Collected
data were manually checked for completeness, accuracy and clarity on daily basis.
3.9. Data processing and analysis
Data were entered into a computer by SPSS version 20 for analysis. Description of
means frequency, proportion and rates of a given data for each variable was calculated.
Bivariate analysis was done to see the association of each independent variable with
the outcome variables and those predictor variables which had a p value ≤ 0.2 was
entered in to multivariate logistic regression model to identify the effect of each
explanatory variable on the outcome variable. A p-value ≤ 0.05 was considered as
statistically significant variables and adjusted odds ratio with 95%CI was calculated to
see the association.
3.10. Variables of the study
3.10.1. Dependent variable
Adherence to iron/folic acid supplement
3.10.2. Independent variables
Socio economic and demographic factors
 Age
 Religion
 Marital status of the mother
 Place of residence
 Family size
 Educational status
 Educational status of the husband
 Occupation of the mother
 Occupation of the father
 House hold monthly income
Supplement related factors
 Duration of supplement
 Method of intake
12
Pregnancy and health related factors
 Parity
 History of still birth
 History of abortion
 Number of ANC
 Place of ANC
 Time of ANC start
 Knowledge of anemia
 Knowledge of benefits of IFA
 Presence of other disease
Health care and system related factors
 Distance from health service
 Number of supplement per visit
 Health education at the time of supplement collection
 Number of IFA supplement collected per visit.
3.11. Operational definitions
Adherence: mothers are said to be adhered to IFA supplement if they took 65% or
more of the supplement, equivalent to taking supplement at least 4 days a week during
three months period (25, 26, and 35).
Non adherence: pregnant mother is said to be not adhered to IFA supplement if they
took less than 65% of the supplement, equivalent to taking supplement less than 4 days
a week during three months period (25, 26, and 35).
Knowledge to anemia:
Those who score mean value and above of questions asked about cause,
consequence, risk group and method of prevention of anemia are considered as having
good knowledge of anemia.
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And those who score less than mean value of questions asked about cause,
consequence, risk group and method of prevention of anemia are considered as having
poor knowledge of anemia.
Knowledge to benefits of Iron/folic acid
Those who score mean value and above of questions asked about benefits of iron/ folic
acid are considered as having good knowledge of benefits of iron folic acid.
Those who score mean value of questions asked about benefits of iron/ folic acid are
considered as having poor knowledge of benefits of iron folic acid.
Postnatal Period: the period between delivery to forty five days.
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4. Ethical consideration
First ethical clearance was obtained from the ethical review bord (IRD) of institute of
Public Health, University of Gondar and offered to bale zone Health bureau and Goba
woreda Health office. Then the woreda health office sends Official letters to local
Authority of all kebelles.
The purposes and importance of the study was explained and informed consent was
secured. Confidentiality was maintained at all level of the study .Participant’s
involvement in the study was on voluntary basis and that they can withdraw any time if
they wanted.
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5. Dissemination and utilization of result
The result of the study will be disseminated to institution public health, university of
Gondar as part of MSc in Applied HumanNutrition thesis, Oromia Health beuraue and
other responsible bodies.
The result will be presented in different seminars, meeting conference and workshops.
Moreover effort will be done to publish the findings of the study in reputable journals.
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6. Result’s
6.1. Socio-demographicand economic characteristics
A total of 405 third trimester pregnant and PNC mother were included in the study. The
mean age of the respondents was 26.3 ±5.1 years. Around 35.6% of respondent were in
age group of 21-25 years and about 28% were in age group of 36-40 years.
Majority of the women interviewed were married (98.1%) and rural dwellers 83.2 %.
About 32.1% of the respondents were unable to read and write, 27.4% can only read and
write, 13% had primary school level and 19.5% had secondary school level, the
percentage of pregnant women who had college and university level were 7.7 %.
Regarding occupation majority of the respondent were house wives 72.6. (Table 1)
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Table 1: Socio-demographic and economic characteristics of pregnant and PNC
mothers, Goba woreda, South East Ethiopia, May 2014 (n=405
Variable frequency Percent
Age 16-20
21-25
26-30
31-35
36-40
51
144
132
50
28
12.6
35.6
32.6
12.3
6.9
Marital status single
Married
Divorced
widowed
15
370
4
16
3.7
91.4
1.0
4.0
Religion l Orthodox
catholic
Muslim
protestant
174
6
213
12
43.0
1.5
52.6
3.0
Residence rural
Urban
337
68
83.2
16.8
Family size < 4 family
4-7 family
>7 Family
71
253
81
17.5
62.5
20.0
Educational level Can t read and write
Can read and write
Primary
secondary
Above secondary
122
117
53
84
29
30.1
28.9
13.1
20.7
7.2
Occupation mother House wife
Governmental employee
Private employee
Daily laborer
Merchant
Farmer
294
41
18
11
24
17
72.6
10.1
4.4
2.7
5.9
4.2
Educational level of
husband
Can t read and write
Can read and write
Primary
secondary
Above secondary
80
116
59
117
33
19.8
28.6
14.6
28.9
8.1
Occupation of
husband
Governmental employee
Private employee
Daily laborer
Merchant
Farmer
58
47
12
27
261
14.3
11.6
3.0
6.7
64.4
Household income <500 birr
500-100 birr
>1000 birr
174
159
73
42.7
39.3
18
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6.2 Pregnancy and Obstetric related characteristic of respondent
Half of the respondents had less than three times ANC visit. Around eleven percent of
the respondents have history of abortion and 3% have history of still birth.
Among the respondents 21.7% have started ANC while their pregnancy is less than
12weeks gestation, and 26.7% have started after 24 week of gestation (Table 2).
Table 2: pregnancy and obstetric related characteristics of respondents in Goba
woreda, South East Ethiopia, may 2014(n=405)
Variable Frequency Percent
Gravidity <3
≥3
302
103
74.6
25.4
Still birth Yes
No
12
393
3
97
Abortion Yes
No
47
358
11.6
88.4
No of ANC >3
<=3
199
206
49.1
50.9
Time of start
Of ANC
<12 week
12-24wk
>24 wk
Health post
88
209
108
73
21.7
51.6
26.7
18
Place of ANC Health center
hospital
277
55
88.4
13.6
Presence of health
problem during
pregnancy
Yes
No
23
382
5.7
94.3
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6.3. Respondent’s knowledge about anemia and benefit of IFA supplement
Around two third (62.5%) of respondents had good knowledge on cause, consequence,
risk group, and method of prevention on anemia, while 60.7% of respondents had good
knowledge on benefits of IFA.
Table 3: Respondents knowledge about anemia and benefit of IFA supplement
Goba woreda, South East Ethiopia, May 2014(n=405)
Variable Frequency Percent
Knowledge on
anemia
Good
Poor
253
152
62.5
37.5
Knowledge on
benefits of
IFA
Good
poor
246
159
60.7
39.3
6.4. Service related characterstics
About (78.9%) were provided with Health education and (21.1) were not provided.
Regarding dispensing of supplement majority of respondents (87%) was collected thirty
tablet and (12.8% ) were collect more than thirty tablets per visit. (Table 4)
Table 4: Service related characterstics Goba Woreda, South East Ethiopia, May
2014(n=405)
Variable Frequency Percent
Health education Yes 319 78.8
No 86 21.2
Waiting time < 30 minute 354 87.4
>30 minute 51 12.6
Problem faced Yes 93 23
No 312 77
Total
Number of tab
supplemented per visit
30 tab 353 87.2
>30 tab 52 12.8
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6.5 Adherence level of women to iron/folate supplementation during
pregnancy
It was found that 82 % of women had poor adherence, while only 18 % of them had
adhered to iron/folic acid supplement.
Figure 2:  Adherence level of mothers to IFA in Goba Woreda, South East Ethiopia,
May 2014
82%
18% adhered
not adhered
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5.6. Reasons for not taking the the supplement
This study found that the reasons for poor adherence to iron/folate supplement among
women were forgetfulness (%), side effects (%), too many pills due to fear of side effect
long term taking of iron tablets (%),fear of having big fetus(%) supplement shortage at
health facility(%) lack of information(%) .(Figure 2)
Figure 3: Reasons for not taking the supplement Goba woreda, South East
Ethiopia, May 2014
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5.7. Factors Associated with Adherence
Bivarete analysis for adherence to IFA reveald that place of residence educational
status of mother, education level of the husband, history of abortion, knowledge on
anemia, knowledge on benefits of iron folic acid health education at the time of
supplement collection and problem faced have association with adherence at p value
≤0.02.
Multivariable logistic regression was done to control potential confounders and
educational status of mother, history of abortion, knowledge on anemia, knowledge on
benefits of iron folic acid and health education at the time of supplement collection have
significant association with adherence at p value ≤ 0.05(Table 5).
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Table 5: Factor associated adherence to IFA at Goba Woreda, South East Ethiopia,
May 2014(n=405)
Factors Adherence status of
respondent
COR 95 % CI AOR 95 % CI
adhered Not  adhered
Place of
residence
Rural cd
Urban
54
19
283
49
0.49(.26,.90) 0.69(.31,1.5)
1 1
Educational
status of
mother
Can t read and write 9 113 0.20(.7,.60) 0.11(.026,.47)
Can read and write 20 97 0.54(.21-1.390 0.23(.064,.87)
Primary education 8 45 0.46(0.15- 0.24(.63,.97)
Secondary
education
28 56 1.31(0.51-3.33) 0.97(.32-2.8)
Above secondary 8 21 1 1
Educational
status of
husband
Can t read and write 10 70 0.38(0.13-1.04) 1.31(.34,4.9)
Can read and write 16 100 0.42(0.16-1.08) 1.30(.37-4.4)
Primary education 13 46 0.75(0,28-2.75) 3.3(.90-12.3)
Secondary
education
25 92 .72(.29,1.75) .85(.30,2.3)
Above secondary 9 24 1 1
History of
abortion
Yes 15 32 2.4(1.23,4.7)
1
3.79(1.68-8.55)
1No 58 300
Knowledge on
anemia
Good 58 195 1
.36(.20,.67)
1
0.41(.20-.84)Poor 137 15
Knowledge on
benefits of
iron folic acid
Good 56 190 1
.40(0.22,0.72)
1
.38(.20,.77)Poor 17 142
Health
education at
the time of
supplement
collection
Yes
No
68
5
251
81
4.3(1.71-11.2)
1
4.03(1.4,11.5)
1
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7. Discussion
This study revealed that only 18% of the studied subjects had adhered to IFA
supplement.
This figure is lower than a study conducted in Kenya, which was 24.5% (25). Other
studies conducted in Cambodia showed an adherence of 47% (26). Another study done
in in India showed an adherence of 35.5% (29). This could be due to the fact that the
present study includes both rural and urban population and differences in
socioeconomic status of the study population. But the finding is much higher than 0.4%
reported by EDHS (201). This could be because the present study was conducted
among ANC follower and health extension worker were assigned in urban area too.).
Educational status of mother was important socio demographic factor which showed
significant association. The adherence rate significantly increases with educational
status. Mothers who can’t read and write were 91, mothers who can read and write
were 77, and mothers who had primary education were 76 times less likely to adhere to
IFA when compared with those who had above secondary education.
Women with better education level are more likely to adhere; this might be because,
when women are educated, they might have access to information and advices from
different sources about IFA and threats of anemia.
Another important variable that showed significant association is knowledge of cause
consequence risk group and method of prevention of anemia. The rate of adherence to
IFA is 59 times less likely among women with poor knowledge.
This finding is similar with the study done in Bangladesh which identifies high proportion
of adherence among pregnant mothers with good knowledge (34). This could be due to
reason that knowledge of pregnant women about anemia in respect of causes
consequence and method of prevention affect their adherence of IFA In addition good
level of knowledge about anemia was a factor which could promote individuals in
preventing iron deficiency anemia and following recommendation.
It was found that there was a significant association between respondent’s knowledge
on benefit of IFA and adherence. Woman with poor knowledge on benefit of IFA were
62 times less likely to adhere than womens with poor knowledge on benefit of IFA.
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This could be due to good level of knowledge on benfits of IFA supplement individuals
in preventing iron deficiency anemia properly taking of supplement and to follow
recommendation.
The other important factor which has association with adherence was Health Education
during prenatal visit. This study show that mothers who were provided with health
education at the time of dsspensing supplement had about 4.03 times more likely to
adhere to IFA supplement than those who were not provided.
A study conducted in Senegal showed failure to provide Health education by health care
providers as major barrier to adherence. Another study conducted in Nigeria showd a
strong association between counseling and adherence. This could be due to the fact
that health education at the time of supplement provied important information of IFA
supplement
The other factor which has association with adherence was abortion; mothers with
history of abortion were 3.7 time adhered to IFA compared with those without this may
because at health institution mothers with abortion counseled and supplemented with
IFA this may improve their knowledge and practice.
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8. Strength and limitation of the study
8.1. Strength of the study
 It is one of the few studies at community level for assessment of adherence to IFA.
8.2. Limitation
 Gold standard method of measuring adherence like electronic and pills counting
method were not used as it is expensive and due to time constraint
 Recall bias
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9. Conclusion
The adherence rate to IFA supplements is low among pregnant women attending ANC
educational status of mother, Knowledge about anemia, Knowledge about benefits of
iron folic acid, health education at the time of supplement collection were factors
affecting adherence to IFA.
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10. Recommendation
For community leaders
 Increase awareness of the community about importance of IFA supplementation during
pregnancy.
For ministry of Health and the regional health Bureau
 The Ministry of Health and the regional health bureau should ensure that there is
continuous and timely supply of IFA to all health facilities. This will enable all pregnant
women to access the supplements from the health facility during their ANC visits.
 Ministry of Health and Regional health bureau should conduct training  courses about
knowledge of anemia and benefits of IFA for health personnel who work at antenatal
care units
Woreda Health Bureau
 Sensitization of the community about anemia and IFA supplement through health
Education.
 Outreach services to enhance access to the supplements or engaging the extention
health workers in  distribution of the supplements.
Other Sectors (Education Bureau, Women and Children’s Affair And Nome
Governmental Organizations Working On The Area)
 Improving the educational status of women
Researcher and scientific community
 Further researches on  IFA using Gold slandered methods
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12. Annex
12.1. Annex1: consent form and information sheet
Informed consent form for third trimester pregnant and PNC mother who are living in the
woreda and have be invited t take part in the study
Title of the research: Adherence to prenatal iron/folic acid supplement and associated
factor among ANC attendant mother s of Goba Woreda, oromia regional state, south
east Ethiopia
Name of Principal Investigator: Mekonnen Tegegne
Advisors: Professor Melkyie Edris
Mr Molla Mesert (Bsc,Msc
Organization: University of Gondar, College of Medicine and Health Sciences, Institute
of Public Health
Name of the Sponsor: university of Gondar
Information sheet and Consent form prepared for mothers prior to the study to
participate in this Research Project.
Part I: Dear Miss /Mrs
Hello, my name is ______________ I am working in a research team of Gondar
University College of Medicine and Health sciences. We will give you information and
invite you to be part of this research you can talk to anyone
If there are any word that you don t understand while I am giving the information, please
stop me and ask me and I will explain it to you.
If you have any question in the later time, you can ask me by using my phone number
which is ………………………or you ask Mekonnen Tegegne, the principle investigator
his phone number: 0911 95 92 72
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Purpose of the study
The aim of this study is to Assessing adherence to iron and folate supplement among
pregnant mother and its associated factors.
Benefits, Risk and /or Discomfort
By participating in this research project is you may feel some discomfort in wasting your
time (a maximum of 30 minutes) .However, your participation is definitely important to
assess adherence to iron and folate supplement among pregnant mother and its
associated factors in Goba town. There is no risk or direct benefit in participating in this
research project.
Incentives/Payments for Participating
You will not be provided any incentives or payment to take part in this project.
Confidentiality
The information that we collect from this research will be kept confidential. Information
about you and your family that is collected during the researches will be handled in a
secure way and no one but the researcher will be able to see it. We will also keep the
confidentiality by using codes instead of any personal identifiers and is meant only for
the purpose of the study
Right to Refusal or Withdraw
You will not be forced to participate; you have the full right to refuse and have the right
to discontinue the process at any point in this research.
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Person to contact
This research project will be reviewed and approved by the ethical committee of the
University of Gondar. If you wish to find about more or if you wish to ask any question,
you can use the contact address below.
1. University of Gondar: Professor Melkyie Edris  and Mr molla Mesert
Tel:   ................................................................
P.O.Box: ………………………………………
Fax ……………………………………………….
E-mail …………………………………………….
2. Name: Mekonnen Tegegne
Tele: +251-911 95 92 72
E.mail-tegegnemekonnen19@Gmail.com
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12.2. Annex2: English Questionnaires
Our study focuses to assess adherence to iron supplement during pregnancy and
associated factors
Dear Miss /Mrs
Hello, my name is ____________________ I am working in a research team of Gondar
University College of Medicine and Health sciences. This questionnaire is prepared to
conduct a study on adherence to iron and folate supplement during pregnancy among
pregnant women and its associated factors. You are selected and included in the study
as part of the sample population to complete the questionnaire designed by the
researcher because you fulfill requirement for sampling. The finding of this study will
help to provide adequate supplements to pregnant women.
Thus this interview is prepared for this purpose to get appropriate data on the study we
are conducting.  The data that I will obtain using this interview will be used only for
research purpose and your response will be kept confidential. For this purpose your
name will not be written here and there will be no way of linking your individual
responses to the final result of the study findings. The study has no risk to you and your
child except sparing a maximum of 30 minutes of your time and if you face any problem
in relation to the research you can contact responsible person based on the address
below. You  have  the  right  not  to  respond  at  all  or  to withdraw  in the meantime,
but  your  participation is highly valuable for  the  success of our research objectives.
Therefore, I politely request your cooperation to participate in this interview
Do you agree to participate in this study? Yes, ------ continue
No-------,
Thank you!
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Name of the data collector____________ Signature ___________Date ___________
Questionnaire code_____________
House number_________________
I. Socio-Demographic and economic Characteristics
S.No Questions Response  categories Skip
101 Age in years …………………
102 What is your current
Marital status?
Single………………….…1
Married …………….…....2
Divorced…………………3
Widowed …………….…..4
103 Which Religion you
are following?
Orthodox………………....1
Catholic…………….….….2
Muslim…………….…......3
Protestant ……….….…...4
Others…………………5 (specify)
104 Place of residence Rural……………………..1
Urban…………………….2
105 Total Family size ………………………….
106 What is your
educational status?
Can’t read and write ……...1
Can read and write ……..…2
Primary (grade 1-8) …….…3
Secondary (9-12) …….…...4
Above secondary (collage
university) ………….5
107 What is your current
Occupation?
House wife…………………..1
Government employee……..2
Private employee ……….….3
Daily labourer ……..…..…....4
Merchant…………..…….…..5
Farmer ………………….…....6
Others ……………………
(Specify)…………….……..... 7
108 What is the
educational level of
can’t read and write……....1
Can read and write….….…2
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II. Pegnacy and health status caracterstics
your Husband? Primary (grade 1-8) ………3
Secondary (9-12)…...........4
Above secondary ……..…5
109 What is the current
occupation of your
husband?
Farmer ………………….….1
Government employee…’….2
Private employee ………..…3
Daily labourer …….……......4
Merchant…………….……..5
Others ……………(specify)6
110 What is the average
Monthly income of
your family?
………………….……..Eth. Birr
S.N
o
Questions Response  categories Skip
201 How many pregnancies have
you had till now?(in number)
…………………...
202 How many deliveries you had
till now?
……………………
203 Did you have history of Still
birth?
Yes……………..…1
No ……………..…2
2------->204
204 If yes, How many still births did
you have?
…………………
205 Did you have history of
Abortion?
Yes ………….…..1
No………….……2
2------>207
206 If yes, How many abortions do
you have?
…………………
207 Did you receive antenatal care
for the recent pregnancy?
Yes…………..….1.
No …………..…2.
2------->211
208 How many times did you
receive ANC?
1……………….……1
2………………….…2
3………………….…3
4……………….……4
>4…………………..5
209 At what gestational age did
you start ANC? …………………weeks
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III. Knowledge on anaemia and its prevention
Ser.N
o
Questions Response  categories
301 Do you know any
illness called anemia?
Yes…………….………..1
No ……………….….……2
2------->304
302 Do you know the
cause?
Yes………………….…..1
No ………………………2
2------->304
303 What is the cause? Unbalanced diet …..….1
iron/folate Deficiency ..2
Loss of blood ………....3
Being worried…………4
Other …………..…. (specify)5
304 Do you know what
anemia resulted in
pregnancy
(consequence)?
Yes …………………..…1
No ………………….…..2
2------->306
305 What are they? (more Maternal mortality…….…1
210 Where did you receive the
ANC?
Health post ……….…1
Health centre ……..…2
Hospital ………..…….3
Other…….. (Specify) .4
211 Did you have any health
problem during this
pregnancy?
Yes------------------1
NO------------------2
2------->skip to
301
212 Tell me which health problem
you have faced?
Hypertension…………1
Diabetes mellitus…......2
Heart disease …………3
Ant partum
Hemorrhage…………...4
Tuberculosis ………….6
Other ………...specify 5
213 Have you taken medication for
the problem during this/recent
pregnancy?
Yes …………...…….1
No ….………....…….2
214 For how long did you take the
drugs during pregnancy? ………………………da
ys
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than one answer is
possible)
Still birth ……………...…2
Infant mortality ………….3
Impaired development
consequences of children’s
.4
Increased blood pressure
…5
Other…………(Specify)…5
306 Who are the most
susceptible groups to
anemia (more than one
answer is possible)
Pregnant women……..….1
Children’s………………….2
None pregnant women…..3
Male adults ……………….4
Other………..…Specify ..5
307 Is anemia during
pregnancy can be
prevented?
Yes …………...…… 1
No …………..………2
2------->401
308 How dose anemia in
pregnancy can be
prevented?(more than
one answer is possible)
Supplementation with
iron/folate tablet………...1
Consumption of food rich in
dietary iron/folate ……….2
Avoidance of food that
interfere with bioavailability
of iron/folate ………………3
Othe………….(specify)…4
309 What is your source of
information Source  of
information
Health workers ….……..1
Media…………….………2
Friends …………..………3
School …………..……….4
Other...............(specify)….5
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IV. Knowledge on iron/foliate supplement
Ser.N
o
Questioner Response  categories
401 Do you know the drug called
iron/folate? (show the strip)
Yes……………..1
No……….………2
2------->404
402 Do you know the benefit of
iron/folate supplement?
Yes………………3
No ……………….4
2------->404
403 what is its benefit of taking
iron/folate supplement (more
than one answer is possible)
Prevent maternal death…1
Prevent infant mortality….2
Prevent Birth defects..…..3
increase maternal blood...4
Give strength for the
mother……………...6
Other…………..…specify.7
404 Do you think that iron/folate
supplement has risk?
Yes………………………1
No ………………………2
2------->405
405 What are the risk of
supplementing iron/folate
supplement
Harm fetus growth …..1
Cause bigger fetus……2
Result in complicated
delivery ……………….3
Other …………….pecify)
406 For how long does the
supplement should be taken?
One month ……………..1
Two months……...……..2
Three months…………3
More than three
months ………………..4
I don’t now……….…….5
Other………….(specify)6
407 What is your source of
information about iron/folate
supplement(more than one
answer is possible)
Health workers …………1
Media…………….………2
Friends ………….………3
School ………….………4
Other............(specify).....5
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V. Adherence to iron/folate supplement related factor
Ser.No Questions Response  categories
501 Have you taken iron/ foliate
supplementation for current
pregnancy?
Yes……………….……1
No………………….…..2
2-------
>503
502 For how long did you take the
supplement?
1 month………….………....1
2 month……………..……....2
3 month………………..…....3
>3 month………………...….4
Other …………….(specify)..5
503 How did you take your
supplement?
On daily base……………....1
Weekly……………..………2
When I think I am sick……..3
Other ……………(specify).4
504 For the first month of supplement
How many tablet/days did you
take in the first month of
supplement?
…………………….tabs
505 For the second month of
supplement. How many
tablet/days did you take in the
second month of supplement?
……………………….tabs
506 For the third month of supplement
How many tablet/days did you
take in the third month of
supplement?
……………………..tabs
507 How many tablets/day did you
took totally?
……………………tablet/days If > 48
..skip…508
508 If, you had taken < 48 tablets( < 4
tabs per a week) (or less than 48
days),What was reason for not
taking the supplement
properly?(more than one answer
possible, but choice doesn’t
allowed to read)
Forgetfulness………………1
Because of too many pills…2
Fear of  side effects…….…3
Unpleasant test……………4
Fear of high birth weight…5
Fear of difficulty in delivery...6
Fear of harm to fetus …...7
Failure to get adequate
supplement in the  health
facility …………….…. 8
Long waiting time at health
facility ………………….9
Service is far from my
residence ………………10
Poor health care provider
communication…………….11
Lack of information about
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VI. Health care and system related factor
how long to take
…………….…12
Other…………….(specify)..13
509 If the answer to question No 508 is
due side effect (choice 3), which
side effects were   responsible
(more than one answer is possible)
Vomiting …………….1
Diarrhea ……………..2
Constipation………….3
Heart burn…………….4
Abdominal cramp……5
Other……..(specify)…6
510 If you had taken ≥ 48 tablets (≥48
tabs per a week) (≥48 days), what
motivates to continue
supplementation? (more than one
answer is possible)
Free of charge……….……..1
Reminding technique use….2
fear of illness………………3
Clinician  instructed and
explained to take the tablets.4
Knew that the tablets would
‘increase their blood………5
Other…………(specify)…..6
Ser.No Questions Response  categories
601 How long it take to reach Health
institution from your residence
……………………….hour
602 Is there any health education about
iron/folate supplement during collecting
your supplement?
Yes …………………1
No …………….…….2
603 If your answer to question No 602 is
yes, what was the issue?
Purpose of supplement..1
Duration of the
upplement………….…..2
Side effect ………….….3
Follow up visit …….…..4
Other………..,….specify 5
604 How many tablets did you collect per
visit
30 table………….….1
60 table………….….2
90 table….……….....3
>90 table……………4
Other ..…..(specify)..5
605 What is the average Waiting time in the
health facility while you were collecting
iron/folate supplement
…………………(minute)
606 Do you face any problem in the facility
while you are collecting your
supplement?
Yes ……………1
No …………….2
607 If the answer to question number 606
is yes, which problem do you face
Shortage of supplement
in the facility …………….1
Long waiting time in the
health
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Thank you for your Participation!
institution……………….2
Poor health care
provider
communication…….…..3
Other……….…Specify..3
45
12.3. Annex 3. concent form Oromic
Gaffin ulfaa dabalata hanqu egaa haalaa fudatmuu fii sababni adaabasuuf kaan
gafatamuu
Oboo/adaa
Maqaa koo…………………………………………………………………………..kaan
jedama unvirsity Gondar keesa kaan hojedhu dha messensa qoranoo dha.
Gaafiin Qooraanoo kuun kaan irraatii xiyyafaatu motummaa naaanoo oromiyaa zonni
baalee magaallaa Goobaa kessatii hadhootaa ulffaa iratii wayee hanqiinaa dhigaatiifi
toofataa ittin ittasanniifi maalife dabalaatan qorssa hanqiinaa dhigaattiif keenamu
malifee akka hin fudhanee addan basuu ilaala.
Akkum Oliratii ibsus ebsameeti qoranoon kuun kaan xiyefatuu hadholeen ulfaa tani fii
dalatanii bulii 45 kaan hin calee faydamuma qoricha dabalataa hanqena  egaa kaan
ilaaletu dha. Issinlee qoranoo kaanaraa akka hiormattan afeeremtani jirtu.debee issin
kenitaan hichittin kaan qabatamu akka tau issinfi ibssa saabab kaanf maqaa kesaan
warqaa irratii akaa hin galmoofene issa ibssa, gafille kaa yarro daqiqa sodoma fudachu
malee rakoo tokoo lee issiniraa akaa hin modatuu akka tae eta u ibbsa
Qoraano irra hirmachuuf waligaltanii jiruu
eyee mitii
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12.4. Annex4: Oromic Questionnaires
maqaa gafilee kaan guratuu------------------------ malatoo---------------- guyaa-------------
koodii-------------- lakk. manaa ---------------
Hadoleen kininaa dabalataa hanqeinaa egaa fudataa  haalaa akami akka
fayaadaman gafilee ilaalaan
I. gaafilla hawwasuma fii dinegdee
Lakkofs
aa
Gafiwaan Debii fi ramadii
101 Urmii  kee
meqaa\hangaamii\
……………(yrs)urmii
102 Heeumitttaa? kan hermitee……………………….1
kan hikkite  …………………………..2
kana ban manaa irradudhee……...3
kan hinheruminee…………………..4
103 Amantaan keemaal Ortodoosii……………………………..1
Katolikii ………………………………2
Musilimaa……………………………3
Protesitaanitii………………………..4
Kan biraa yoo jiratee………… ibsii 5
104 Jirun kee esaa adeya…………………………………..1
Magala………………………………..2
105 Walii galaan mateen kee
meqaa
……………………………………….
106 Hangambaretee\hanga
meqaa barratee?
baresufi dubisu kanhidandenyee.1
Baresuf dubiisudanda’u………..2
Sadarkka tokkoffa) KUtaa 1-8 kan
baratee……….3
Sadarkka lammaffa (9-12) kutaa 9-
12kan baratee………4
Kutaa kudhaa lamma oli………5
107 Hojii kee maal? Hadhaa mana…………………...1
Hojetaa mootumaa …………….2
Mitii  mootumaa………………..3
Hojii guyaa……………………....4
Daldaalaa………………………5
Qonaa.. …………………………6
Kan biraa ibsii……………..……7
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108 Abaa mana kee hangaa
meqaa bartee?
baresufi dubisu kanhidandenyee..1
Baresuf dubiisudanda’u……….2
Sadarkka tokkoffa) KUtaa 1-8 kan
Baratee……………………………….3
Sadarkka lammaffa (9-12) kutaa 9-
12kan baratee…………………..4
Kutaa kudhaa lamma…………..5
Oliikanbarate……………………….6
Kan biraa ibsii……………………7
110. Jidhaan qarshii hangam
argata?Qarshiin hangamii
………………………………………….
II. gafilaa ulfaa fii fayaa ilaalan
Lakkofsaa Gaafiwaan _________________ulfaa
201 yeroomeqaa dhulfoftee hanga
ammatii
_________________daimaa
202 Ijolee meqaa qabidaa? _________________
203 Kaan gara  keesa due
dhalatee jiraa
Eeyenii……………….1
MItii……………………2
204 Eeyeni yoo jatee meqaa ……………………….
205 Daimaa kaan garaa kessa
bade jiraa jiraa
Eeyenii……………….1
MItii……………………2
206 Eeyeni yoo jatee meqaa ……………………….
207 Dhulfaa amma kanaf yalaa
dahumisa durra  wordoftee?
Eeyeni…………………....1
Mitti,………………………..2
208 Yeroo meqaaf yalaa
dahumisa durra  wordoftee?
1……………………………..1
2……………………………..2
3………………………………3
4………………………………..4
>4………………………………5
209 Ulfaa tatee yaroo kamiin meqaaf
yalaa dahumisa durra ordoftee?
………………………..samutaa
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210 Yalaa\tajajiila\ dahumisan
durra  dhulfaa amma  kanatifi
essa  fudhatee?
Kelaa fayaa……….………..1
Bufata fayyaa………....…….2
Hosiipitaal……….…………..3
Kan irra yo jiratee
ibisii…………………………4
211 Rakkon fayya siiqonamee
jiraa yeroo dulfaa amma
kana?
Eeyenii …………….…… 1
Mitti……………………….2
212 Yoo debii gaffi lakkofsa210
Eeyenii tahee, isaa kamii?
dabalaa dhigaa…………..1
debii shuqaraa……………2
debii wane………………….3
dibee dagalyuu……………4
dibee sonbaa………………..5
kan birr yoo jirrateeibisii…6
213 Rakkon fayya siiqonamee
jiraa yeroo dulfaa amma
kana?
Eeyenii ……………….1
Mitti……………..……...2
214 yeroo hangamifii fudhatee?
III. Gafilee bekumssa hanqinaa egaa halii ittib abaramsu
301 Dibee hanqinaa egaa
jadhamu beeketa?
Eeyenii………………..…………..1
Mitti…………………….……………2
302 Yoodebii gaffii lakkofsa
eeyenii jete maaltu akka
dhukkubaa kanaa fiidu nii
beekitaa?
Eeyenii……………………………1
Mitti……………………………………2
303 Yoo debii gaffiilakkofsaa
01eeyenii jetee   isaa
kmii?
Hanqinaa nyataairaa……………..1
Hanqinaa albudaa iraaa………….2
Dangalawu digaa………………….3
Bayinna yaduu iraa……………….4
Kaan biraa ibsaa………………….5
304 Midhaa  dhukkubinni kunii
dhulfaa irraatii  fiduu maal
akka ta’ee nibekkitaa?
eyenii……………………………………….1
Mitti………………………………………….2
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305 jetee   isaa kamii? Duaa hadholee……………………..1
Duaaa Ijoolee …………………….2
Duaa daimanii………………………..3
Gudataa ijoolee rakoo fiduu……..4
Egaa dabalu …………………………….5
Kaan biraa ibsaa……………………….6
306 Yaroo baynaan dibee
kaanf kaan slxlamayaan
enu fa
Dubaree ulfaa…………………………..1
Daimanii……………………………………2
Dubaroon ulfaa kaan hintane…….3
Dhiraooni…………………………………..4
Kaan biraa yoo jiratee ibsaa………5
307 Dubaree ulfaa hanqinaa
egaa akaa bararsuu
nidandetii
Eeyenii………………………………….1
Mitti………………………………………2
Hinbekkituu…………………………..3
308 Akaame bararsu
dandaema
Dabalataa albudaa kenuu dhani…1
Nyataa dhani……………………………2
Nyata albudaa kaan dowaan hanbisuu dhaan
……………………3
Kaa biraa yoo jiratee ibsaa……..4
309 Odefanoo kaan esaan
argatee
Ogeesafayyaa…………………………1
Odefanoo irraa……………………….2
Wayiilaa …………………………………3
Manaa barmotaa……………………4
Kan biraa yoo jiratee ibisii
IV. Gafilee Bekumsaa qorichaa hanqinaa egaa ilaalu
S
no
401 Kinni dhigaa dabalata niobeytaa?(qoricha
agarsisaa)
Eeyenii ……………………..….1
Mtii ……………………………..2
402 Faydaa Kinni dhigaa dabalata nibaytaa? Eeyenii………………………….1
Mitti ……………………………..2
403 Gafii lak 402 eeyanii you jatee malfaa? Duaa hadholee ni hanbisaaa……....1
Duaaa Ijoolee  ni hanbisaaa ………2
Rakoo Gudataa ijoolee niseressa ..3
Egaani  dabalu……………………..4
Kanbiraa ibsaa…………………..…5
404 Kinn dhigaa dabalata kenaamu rakko
fayya nifidaa
Eeyrni……………………………...1
Mitti…………………………………2
Hinbertuu…………………………..3
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405 Kinn dhigaa fudhachini haadhaafi rakoo
fidu mali?
Daima akaa gudatu dowu ………...1
Daiman likii mala akka gudatu
gochu…………………………………..2
Daumsaa iraa rakoo fidaa……3
Kanbiraa ibsaa………………5
406 Kinn dabalatta hanqinaa dhigaa yarro
meqaaf fudhtamsa
Jia tookoof……………………1
Jia laamafe……………………..2
Jia sadiif ...………………….3
Jia sadii olii……………….4
407 Odefanoo kaan esaan argatee Ogeesafayyaa…………………………1
Odefanoo irraa…………………….2
Wayiilaa ………………………………3
Manaa barmotaa……………………4
Kan biraa yoo jiratee ibisii
V. Gafilee Halee qorichaa fudhatamee kaan ilaaletuu
S.no
501 Ulfaa kannaf dabalataa qorichaa
hanqinaa egaa fudhatee jirtaa
Eeyenii……………….1
Mitti……………….….2
502 Yaroo meqaaffudhatee Jiaa tokoof ………………1`
Jiaa lammafee…………..2
Jiaa sadifee……………..3
Jiaa sadi ol;eef…………4
503 Qoricha akamii fudhachaa turtee Guyaa dhan……………1
Samutaa dhan………..2
Dhukubaa ywaytaa
naadagyamu…………..3
Kabiraa yoo jirate e ….ibsa
504 Jia tokoofa dabalataa qorichaa
hanqinaa egaa fudhchu ilala
Yaroo meqaa fi fudhate
Kininaa…………………….
505
Jia lammafa dabalataa qorichaa
hanqinaa egaa fudhchu ilala
Yaroo meqaa fi fudhate
Kininaa…………………….
506 Jia sadafaa fa dabalataa qorichaa
hanqinaa egaa fudhchu ilala
Yaroo meqaa fi fudhate
Kininaa…………………….
507 Waluma galatee kinina meqaa
fudhatee
Kininaa…………………….
508 Kininaa 48 (guyaa 48) gadii yokiin
samutatii kinina 4 gadii yoo fudhatee
sababini isaa malee?( tokko olii
Dagachudhan ……………….…1
Kinini bayaa waan taeef …….…2
Rakoo kinin fiduu sodachu
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debisuu ni dandamaa) dhan………………………………3
Kinninin waan mararu…………..4
Dhaimini halaa malee nifurdataa
jadhee waan sodadeef……….…5
Dainsaa iraa rakoo fidaa jadhee
waan sodadee……………………6
Diemma nimida jadhee waan
sodadeef…………..…………...…7
Manaa hakimma kesa qorichaa
waan argachu waan hin
andeenef………………..…….…8
Qoricha fudhachuuf wayitaa demuf
waan bayaa natursisaani…….…9
Manaa hakimaa mana kiyaa iraa
byaa waan fagatuuf…………..10
Ogessa fayaa waali galtee qabuu
laaf waan taeef………………...11
Yarroo meqaaf qorichaa akaa
fudhtamu waan hin bekneef....12
Kaan biraa yoojiratee ibsaa…13
509 Gafii lqkk         deebi issa Rakoo kinin
fiduu sodachu dhan 3 yoo taee saaba
kamii
Bulgafachuu………….1
Bassa …………..…….2
Garra goguu………….3
Lapee gubuu…………4
Garaa muruu…………5
Kaan biraa yoojiratee
ibsaa………………….6
510 Kininaa 48 (guyaa 48) olii  yokiin
samutatii kinina 4 olii yoo fudhatee
sababini isaa malee?( tokko olii
debisuu ni dandamaa
Qoricha bilisaan waan
keenmu……………………………1
Qorichaaa fudhchuuf yadanoo
waan faydamu………….……..…2
Dhibee waan sodadu…………....3
Ogesii akaa sirtii fudadu waan
najajeef……………………………4
Egaa akaa dablu  waan bekuuf...5
Kaan biraa yoojiratee ibsaa……6
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VI. Gafilee kununsaa fayaa fii systamii issaa kaan ilalatu
S.No Gaffiwaan Dibii fi ramadii
601 Bakaa tajjajilii fayaa itti keenamuu
hangamii sii irra fagata
……………………………daqiqa
602 Barumsaa  yeroo kinni dabalata
fudhatan argatan
Eeyenii……………………………..1
Mittii……………………………………2
Hinbekuu…………………………….3
603 Gafii lakofsa 602 eyaa yoo taee
waayaa maalifii
Fyeeda qorichaa dabalata egaa….1
Yaroo meqaaf akaa fudhtamu….…2
Dabalataa rakoo fiduu……………..3
Bufataa faatii irr ayarro maqatiin
akasa argamu………………………4
Kan biraa yo jiratee ibsaa…………5
604 Yaroo tokoon Dawwa meqaa
argata ?
Kinina 30…………………………….1
Kinina 60……………………………2
Kinina 90…………………………….3
>Kinina 30…………………………..4
605 Bakaa tajjajilii fayaa itti hagaam
turtaa ……………………………………….
606 Taajjjilaa  argachuuf waytaa
damituu rakoo sitii qunamee
beketuu?
Eeyenii……………………………..1
Mittii……………………………………2
Hinbekuu…………………………….3
607 Gafii lakofsa 606 eyaa yoo taee
waayaa maalifii
Hanqinaa qoricha dabalta egaa……1
Yaroo bayaa turuu…………………..2
Waligaltee ogesotaa fayaa dadaba
tau………………….…………………3
Kan biraa yo jiratee ibsaa…………5
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12.5. Annex 5. የአማርኛ ሰምምነት
በእርግዝና ወቅት ተጨማሪ የደም ማነስ መከላኬያ መዳህኒትን አጠቃቀም ና ተጎዳኝ
ምክንያቶች ለመለየት የተደረገ ጥናት
የተከበሩ፡- ወ/ሮወይምወ/ሪት
ስሜ……………………………የተባልኩኝ እኔ የጎንደር ዩኒቨርሲቲ የህክምናና ጤና ሳይንስ
ኮሌጅ የጥናት እና ምርምር ባልደረባ ነኝ፡፡ከላይ እንደጠቀስኩት ይህ የጥናት መጠይቅ
የሚያተኩረዉ በ ጎባ ከተማ ነብሰጡር እና ወልደው ቀን ባለልሞላቸዉ እናቶች ስለ ተጨማሪ
የደም ማነስ መከላከያ አጠቃቀምን በ ተመለከተ የተዘጋጀ ሲሆን እርሰዎ ለጥናቱ
የሚያስፈልጉ መስፈርቶችን አሟልተዉ በመገኘተዉ የጥናቱ አካል አድርገንዎታል፤ስለሆነም
የጥናቱ ግኝት ለእርሰዎ እና ለሌሎች እናቶች ጠቃሚ የጤና እንክብካቤ እንዲያገኙ ይረዳል ፡፡
በመሆኑም ይህ መጠይቅ ሲዘጋጅ ተገቢ የሆኑ መረጃዎችን ለማግኘት ሲሆን ከእርሰዎ
የሚገኘዉ መረጃም ለጥናት እና ምርምሩ ተግባር ብቻ የሚዉል ነዉ፡፡እርሰዎ የሚሰጡት
ምላሾች ሚስጥራዊነታቸዉ የተጠበቁ እንደሚሆን እየገለጽኩኝ ለዚህም አላማ ሲባል የእርሰዎ
ስም በመጠይቁ ላይ የማይጻፍ እና የጥናቱ የመጨረሻዉ ዉጤት የእርሰዎን የግል ማንነት ጋር
የማይገናኝ መሆኑን ከወዲሁ አረጋግጣለዉ፡፡
በተጨማሪም ይህ መጠይቅ ከ30 ደቂቃ ያልበለጠ ጊዜ ከመሻማት ያለፊ በእርስዎ ላይ ምንም
አይነት ጉዳት የማያደርስ ሲሆን ከጥናቱ ጋር በተያያዘ ለሚከሰቱ ማንኛዉም ዓይነት ጉዳዮች
ከዚህ በታች በተቀመጠዉ አድራሻ ሊያገኙን የሚችሉ መሆኑን እያስገነዘብኩ በጥናቱ ላይ
ያለመሳተፍ እናየ ማቋረጥ መብተዎ የተጠበቀ ነዉ፡፡
የእርስዎ መሳተፍ ግን ከምንም በላይ ለጥናቱ ዓላማ መሳካት ወሳኝ በመሆኑ በመጠይቁ
እንዲተባበሩን ስል በታላቅ አክብሮት እና ትህትና እጠይቃለሁ፡፡
በጥናቱ ለመሳተፍ ፈቃደኛ ነዎት? አዎ አይደልም ፡
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12.6. Annex: 6 የአማርኛ መጠይቆች
መጠ ይቁን የሚሰበስበዉ ሰዉ ስም ------------------------- ፊርማ------------------ ቀን--------------
የመጠይቁ ኮድ -------------- የቤትቁጥር ---------------
የተጨማሪ የደም ማነስ መድሃኒት በወሰዱ እናቶች፡ሰለመድሃኒቱን አወሳሰድ የሚደረጉ ጥያቄዎች
ክፍል I. የማህበራዊና ኢኮኖሚያዊ ሁኔታዎች
ተ.ቁ ጥያቄዎች አማረጭመለሶች ወደሚቀጥለዉ
ማለፍ
101 ዕድሜ _______________ዓመት
102 የጋብቻ ሁኔታ ? ያለጋባች………………1
ያገባች…………………2
አግብታ የፈታች...........3
ባሏ የሞተባት………….4
የተለያየች …………..5
103 የሃይማኖትሁኔታ ? ኦርቶዶክስ…………….1
ካቶሊክ…………….…2
ሙስሊም……………..3
ፕሮቴስታንት…….….4
ሌላ ካለ …………ይገለጽ…
104 የመኖሪያ ቦታ ገጠር…………………1
ከተማ………………..2
105 አጠቃላይ ቤትሰብ
ብዛት
…………………………
106 የትምህረት ደረጃ? ማንበብናመጻፍ አይችሉም-………..1
ማንበብናመጻፍ ብቻ…....................2
አንደኛ ደረጃ ትምህርት ያጠናቀቁ….3
ሁለተኛድረጃ ትምህርት ያጠናቀቁ -----4
ከ ሁለተኛ ደረጃ በላይ (ኮሌጅና
ዩኒቨርስቲ በላይ) --------------…….5
107 በአሁኑስዓት የሚሰሩት
የስራ አይነት ምንድን
ነው?
የቤት እመቤት......................1
የመንግስት ተቀጣሪ..............2
የግል ተቀጣሪ......................3
የቀን ሰራተኛ…....................4
ነጋዴ……………………….5
ግብርና………....................6
ሌላ ካለ …………ይገለጽ…7
108 የባለቤትዎ የትምህርት
ደረጃ ምን ያህል ነዉ
ማንበብናመጻፍ አልችሉም………..1
ማንበብናመጻፍ ብቻ……………....2
55
ክፍል 2 ስነ ተዋልዶ ና የጤና ሁኔታ
አንደኛ ደረጃ ትምህርት ያጠናቀቁ…3
ሁለተኛድረጃ ትምህርት ያጠናቀቁ ---4
ከሁለተኛ ደረጃ በላይ (ኮሌጅና
ዩኒቨርስቲ በላይ) -----------------------5
ሌላ ካለ………………..……ይጥቀሱ..6
109 በአሁኑ ስዓት
ባለቤትዎ የሚሰሩት
የስራ አይነት ምንድን
ነው?
የመንግስት ተቀጣሪ..............1
የግል ተቀጣሪ......................2
የቀን ሰራተኛ…...................3
ነጋዴ……………………….4
ግብርና………..................5
110 ወርሃዊ የኢኮኖሚ ገቢ
ስንት ነዉ?
…....................በኢትዮጵያብር
ተ.ቁ ጥያቄዎች አማረጭመለሶች ወደሚቀጥ
ለዉማለፍ
201 አጠቃላይ እርግዘና? ………………………….…………………….እርግዝና
202 ምን ያህል ልጅ ወልደዋል? …………………………ልጅ
203 ከዚህ በፊት ሞቶ የተወለደ ልጅ
አሎት?
አዎ……………….…………..1
የለም……………….………....2
2-------
>205
204 አዎ ካሉ ስንት? ………………………………..
205 ከዚ በፊት ዉርጃ ነበሮት? አዎ……………….…………..1
የለም……………….………....2
206 አዎ ካሉ ስንት ዉርጃ? …………………………….
207 በዚህ የእረግዝና ግዜዎ ቅድመ
ወሊድ ክትትል በ ጤና ተቋም
አድረገወ ነበር ?
አዎ……………….…………..1
የለም……………….………....2
2-------
>210
208 ለምን ያህል ጊዜ ነዉ የቅድመ
ወሊድ ክትትሉን ያደረጉት?
1………………..….…….1
2…….…..………..……..2
3.………………..………3
4………………..……….4
>4…………….…….…..5
209 በየትኛዉ የእርግዝና ወቅት
ሳምንት/ ነዉ የመጀመሪያዉን
የእረግዝና ክትትል የጀመሩት?
…………………………………ሳ
ምንት
56
ክፍል3 ስለ ደምማነስ ያለቸው እውቀት ለመመልከት የተዘጋጀመጠይቅ
ተራ.ቁ ጥያቄዎች አማረጭመለሶች ወደሚቀጥለዉማለፍ
301 ደም ማነስ ስለ ተባለዉ የጤና
ችግር ያዉቃሉ
አዎ……………..….1.
የለም……………….2
2------->304
302 ምክንያቱን ያዉቃሉ? አዎ………………..1
አለውቀዉም ………2
2------->304
303 ምክንያቱ ምንድ ነዉ? የተመጣጠነ ምግብ ያለመመገብ.1
የብረት መአድን እጥረት……….2
የደም መፍሰስ……………………3
አብዝቶ መጨነቅ……………….4
ሌላ ካለ …………….……..(ይግለ)5
304 በ እርግዝና ወቅት ደም ማነስ
ሊያስከትል የሚችለዉን ችግር
ያዉቃሉ
አዎ……………..….1.
የለም……………….2
2------->306
305 ምን ችግር ሊያስከትል
ይችላል
የ እናቶች ሞት………………….1
የ ህጽናትን ሞቶ መወለድ………2
የ ህጽናት ሞት…………………..3
የ ህጽናት እድገት መዛባት……..4
የ ደም ግፊት መጨመር……….5
ሌላ ካለ ………….……(ይገለጽ).6
306 በብዛት ለደም ማነስ
የሚጋለጡት እነማን ናቸዉ
ነብሰጡር ሴቶች………………1
ህጽናት………………………2
ነብሰጡር ያልሆኑ ሴቶች……3
አዋቂ ወንዶች………………..4
210 እርግዝናዎ ክትትሉን ያደረጉት
የት ነበር?
ጤና ኬላ………………….….1
ጤና ጣቢያ………….………2
ሆስፒታል…………….……..3
ሌላ ካለ …………..ይገለጽ…4
211 በዚህ እርግዝና ወቅት የጤና
ችግር ገጥሞት ነበር?
አዎ………………..1
የለም……………....2
2-------
>301
212 የትኛዉ የጤና ችግር
እንደገጠሞት ቢነግሩኝ?
ከፍተኛ የደም ግፊት………..1
የ ስክዋር በሽታ………..……2
የ ልብ በሽታ………………..3
ከፍተኛ የደም መፍሰስ……..4
የ ሳንባ በሽታ…………….…5
ሌላ ካለ ……………ይገለጽ…6
213 ለዚህ የጤና ችግር በአርግዝና
ወቅት መዳህኒት ወስደዉ ነበር
አዎ…………………………1
አይ………………………….2
2-------
>301
214 ለምን ያህል ጌዛ ነዉ የወሰዱት? ……………………………..ቀን
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ሌላ ካለ …..……………(ይገለጽ)5
307 በእርግዝና ወቅት ደምማነስን
መከላከል ይቻላል
አዎ……………….……..1
አይቻልም……………....2
አለውቀዉም ……………3
2------->309
3------->309
308 እንዴት በእርግዝና ወቅት
የደም ማነስንመከላከል
ይቻላል
ተጨማሪ የብረት መአድንን
በመስጠት………………………...1
በብረት የበለጽጉ ምግቦችን
በመመገብ……..………………….2
የብረት መአድንን በሰዉነታችን
መቆየትን የሚከላከሉ ምግቦችን
በማስወገድ………………………..3
ሌላ ካለ…………………ይገለጽ…4
309 ይህንን ኢንፎርሜችን ኬትነዉ
የሰሙት
ከጤና
ባለሞያዎች……………………...1
ከመገናኛ ቡዙሀኖች……………..2
ከጎደኞች…………………………3
ከትምህርት ቤት…………………4
ሌሎች............(ይገለጽ)…….…..5
ክፍል 4 ስለ ደምማነስ መድሃኒተ ያለቸው እውቀት ለመመዘን የተዘጋጀመጠይቅ
ተራ.ቁ ጥያቄዎች አማረጭ መለሶች ወደሚቀጥ
ለዉማለፍ
401 ተጨማሪ ደም ማነስ
መድሃኒትን ያዉቃሉ?
(መዳህኒቱን ያሳዩ)
አዎ………………..1
አለውቀዉም ………2
2-------
>404
402 የተጨማሪ ደም ማነስ
መድሃኒትን ጥቅም ያዉቃሉ
አዎ………………..1
አለውቀዉም ………2
2-------
>404
403 የተጨማሪ ደም ማነስ
መድሃኒትን ጥቅሞች
ምንድናቸዉ (ከ አንድ በላይ
መልስ መመለስ ይቻላል)
የእናቶችን ሞት ይከላከላል…..1
የህጽናትን ሞት ይከላከላል…..2
የህጽናትን አስተዳደግ ችግር
ይከላከላል………..……….…..3
የደም መጠንን ይጨምራል…..4
ለእናቶችጥንካሬንይሰጣል……..5
ሌሎች...................(ይግለጱ)…6
404 ተጨማሪ የ ደም ማነስ
መዳሀኒት የሚያመጣዉ ችግር
አለዉ ብለዉ ያስባሉ
አዎ……………..1 አይ …….
አለውቀዉም ………3
2-------
>406
3-------
>406
405 ተጨማሪ የ ደም ማነስ የጽንስን እድገት መግታት…….1
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ክፍል 5 ስለ ተጨማሪ ደምማነስ መድሃኒተ አወሳሰድና ተጉዳኝ ምክንያቶችን የተመለከቱ
መጠይቆች
ተ.ቁ ጥያቄዎች አማረጭመለሶች ወደሚቀጥ
ለዉማለፍ
501 በአሁኑ የእረግዝና ግዜዎ ተጨማሪ
የደማነስ መዳህኒት ወስደዉ ነበር?
አዎ……………….1
የለም……………..2
2-------
>503
502 ለምንያህል ግዜ ነዉ የወሰዱት? ለአንድ ወር
ለሁለት ወር
ለሶስት ወር
>ሶስት ወር
503 መድሃኒቱ እንዴት ነበር ሲወስዱ
የነበረዉ
በየቀኑ……………..1
በየሳምንቱ………..2
ህመም ሰማኝ…….3
ሌላካለ ….(ይግለጽ).4
504 በመጀመርያ ወራት ተጨማሪ
የደም ማነስ አወሳሰድን
በተመለከተ
ለምን ያህል ግዜ ነዉ የወሰዱት
…………እንክብል
505 በሁለተኛዉ ወራት ተጨማሪ የደም
ማነስ አወሳሰድን በተመለከተ
ለምን ያህል ግዜ ነዉ የወሰዱት
…………………………እንክብል
506 በሶስተኛዉ ወራት ተጨማሪ የደም
ማነስ አወሳሰድን በተመለከተ
ለምን ያህል ግዜ ነዉ የወሰዱት
…………………እንክብል
507 በጠቅላላዉ ምን ያህል
እንክብል/ቀናት ወስደዋል
…………..እንክብል/ቀናት
508 ከ 48 ፍሬ( 48 ቀናት) በታች ወይም
በሳምንት ከ አራት ፍሬ በታች
በመርሳትዎ…………………...1
በዙ እንክብል ስለሆነ…………..2
መዳሀኒት ሊያሠመጣዉ
የሚችላቸዉ ችግሮች
ምንድናቸዉ (ከ አንድ በላይ
መልስ መመለስ ይቻላል)
ከፍተኛ የጽንስን እድገት
ያስከትላል………………….…..2
ወሊድ ላይ ችግር ያስከትላል….3
ሌሎች..........(ይግለጽ).............4
406 ተጨማሪ የ ደም ማነስ
መዳሀኒት ለምንያህል ግዜ
ነዉ የሚወሰደዉ
ለአንድ ወር...........................1
ለሁለት ወር..........................2
ለሶስት ወር...........................3
ከሶስት ወር በላይ...................4
አላዉቅም..............................5
407 ይህንን ኢንፎርሜችን
ኬትነዉ የሰሙት
ከጤና ባለሞያዎች……..1
ከመገናኛ ቡዙሀኖች…………………..2
ከጎደኞች……………………3
ከትምህርት ቤት……………4
ሌሎች................(ይግለጽ)...5
59
ከወሰዱ ምክኒያትዎ ምን ነበር
?(ከአንድ በላይ ምልስ መስጠት
ይቻላል)
በጎነዬሽ ጉዳቱን ምክኒያት……..3
በ እንክብሉ ጣም ምክንያት…….4
ህጻኑ ከመጠን በላይ ይፋፋል ወይም
ትልቅ ይሆናል ብለው በማሰብ
ነው……......................................5
የመዉለጃ ግዜ ችግር ይፈጥራል ብሎ
በመፍራት……………………….…6
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